Repair Biotechnologies Revenue and Competitors
Estimated Revenue & Valuation
- Repair Biotechnologies's estimated annual revenue is currently $1.6M per year.
- Repair Biotechnologies's estimated revenue per employee is $155,000
Employee Data
- Repair Biotechnologies has 10 Employees.
- Repair Biotechnologies grew their employee count by -9% last year.
Repair Biotechnologies's People
Name | Title | Email/Phone |
---|---|---|
1 | CO-FOUNDER AND CEO | Reveal Email/Phone |
2 | CO-FOUNDER AND CHAIRMAN | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
4 | Scientist I | Reveal Email/Phone |
5 | Scientist II | Reveal Email/Phone |
6 | SENIOR PRINCIPAL SCIENTIST | Reveal Email/Phone |
7 | Scientist II | Reveal Email/Phone |
8 | Scientist 2 | Reveal Email/Phone |
Repair Biotechnologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.6M | 4 | 0% | N/A | N/A |
#2 | $3.7M | 24 | 41% | $44M | N/A |
#3 | $6.2M | 40 | -7% | N/A | N/A |
#4 | $42M | 271 | -1% | N/A | N/A |
#5 | $12.7M | 82 | 0% | $10M | N/A |
#6 | $2.5M | 16 | 0% | N/A | N/A |
#7 | $7.5M | 45 | 0% | $51.6M | N/A |
#8 | $0.2M | 1 | -50% | N/A | N/A |
#9 | $4.3M | 26 | -16% | $3.3M | N/A |
#10 | $3.7M | 24 | 4% | N/A | N/A |
What Is Repair Biotechnologies?
Repair Biotechnologies is a preclinical biotechnology company focused on developing drugs for cholesterol and aging-related diseases. Our first-in-class Cholesterol Degrading Platform (CDP) technology is aimed at reversing atherosclerosis, familial hypercholesterolemias, and other conditions in which excess or modified cholesterol drives pathology.
keywords:N/AN/A
Total Funding
10
Number of Employees
$1.6M
Revenue (est)
-9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 10 | 0% | N/A |
#2 | $1M | 11 | -21% | N/A |
#3 | $1.4M | 11 | 22% | N/A |
#4 | $1M | 11 | -27% | N/A |
#5 | $1M | 11 | -21% | N/A |